Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. Tompkins
    4. ›
  4. 14882
    5. ›
  5. NOVASTERILIS, INC.

NOVASTERILIS, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: NOVASTERILIS, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 31 Mar 2000 (25 years ago)
Entity Number: 2493678
ZIP code: 14882
County: Tompkins
Place of Formation: New York
Address: ATTN: ANTHONY EISENHUT, 3109 N. TRIPHAMMER ROAD, LANSING, NY, United States, 14882
Principal Address: 3109 N TRIPHAMMER, LANSING, NY, United States, 14882

Shares Details

Shares issued 5290000

Share Par Value 0.01

Type PAR VALUE

Chief Executive Officer

Name Role Address
ANTHONY EISENHUT Chief Executive Officer 3109 N TRIPHAMMER, LANSING, NY, United States, 14882

DOS Process Agent

Name Role Address
NOVASTERILIS INC DOS Process Agent ATTN: ANTHONY EISENHUT, 3109 N. TRIPHAMMER ROAD, LANSING, NY, United States, 14882

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Website:
http://www.novasterilis.com
E-Commerce Website:
http://www.novasterilis.com
Phone Number:
607-330-2772
E-mail Address:
tre1@novasterilis.com
Contact Person:
TONY EISENHUT
User ID:
P0703372
Trade Name:
NOVASTERILIS

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
HZMPWKV873R2
CAGE Code:
46VP8
UEI Expiration Date:
2025-11-06

Business Information

Doing Business As:
NOVASTERILIS
URL:
http://www.novasterilis.com
Activation Date:
2024-11-08
Initial Registration Date:
2005-10-25

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
46VP8
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-11-08
CAGE Expiration:
2029-11-08
SAM Expiration:
2025-11-06

Contact Information

POC:
TONY EISENHUT
Corporate URL:
http://www.novasterilis.com

Immediate Level Owner

Vendor Certified:
2024-11-08
CAGE number:
57KY5
Company Name:
IFYBER LLC

Form 5500 Series

Employer Identification Number (EIN):
161589964
Plan Year:
2009
Number Of Participants:
3
Sponsors Telephone Number:
6073302772
File:
View File

History

Start date End date Type Value
2024-01-03 2024-01-03 Address 3109 N TRIPHAMMER, LANSING, NY, 14882, USA (Type of address: Chief Executive Officer)
2023-09-15 2024-01-03 Shares Share type: PAR VALUE, Number of shares: 5290000, Par value: 0.01
2021-11-04 2023-09-15 Shares Share type: PAR VALUE, Number of shares: 5290000, Par value: 0.01
2014-03-07 2024-01-03 Address 3109 N TRIPHAMMER, LANSING, NY, 14882, USA (Type of address: Chief Executive Officer)
2007-12-05 2021-11-04 Shares Share type: PAR VALUE, Number of shares: 5290000, Par value: 0.01

Filings

Filing Number Date Filed Type Effective Date
240103001356 2024-01-03 BIENNIAL STATEMENT 2024-01-03
140307006153 2014-03-07 BIENNIAL STATEMENT 2014-03-01
120511002078 2012-05-11 BIENNIAL STATEMENT 2012-03-01
100329002762 2010-03-29 BIENNIAL STATEMENT 2010-03-01
080402002870 2008-04-02 BIENNIAL STATEMENT 2008-03-01

USAspending Awards / Contracts

Procurement Instrument Identifier:
W81XWH13P0546
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
166000.00
Base And Exercised Options Value:
166000.00
Base And All Options Value:
166000.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2013-09-13
Description:
NOVA 2200 STERILIZING UNIT
Naics Code:
423450: MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS
Product Or Service Code:
6640: LABORATORY EQUIPMENT AND SUPPLIES
Procurement Instrument Identifier:
W911QY13P0303
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
6944.00
Base And Exercised Options Value:
6944.00
Base And All Options Value:
6944.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2013-06-19
Description:
NOVA 2200
Naics Code:
621511: MEDICAL LABORATORIES
Product Or Service Code:
J073: MAINT/REPAIR/REBUILD OF EQUIPMENT- FOOD PREPARATION AND SERVING EQUIPMENT
Procurement Instrument Identifier:
W911QY12P0003
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
6615.00
Base And Exercised Options Value:
6615.00
Base And All Options Value:
6615.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2011-10-11
Description:
MAINTENANCE SERVICES
Naics Code:
621511: MEDICAL LABORATORIES
Product Or Service Code:
J066: MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT

USAspending Awards / Financial Assistance

Date:
2022-07-11
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
NOVAAPI: TERMINAL STERILIZATION OF DRUG SUBSTANCES AND PRODUCTS - PROJECT SUMMARY / ABSTRACT NOVASTERILIS, INC. INTENDS TO DEVELOP AND COMMERCIALIZE ITS NOVEL STERILIZATION PLATFORM BASED ON SUPERCRITICAL CARBON DIOXIDE (SCCO2) AND POWERFUL STERILANT, NOVAKILL™ FOR THE PHARMACEUTICAL MARKET – NOVAAPI™. STERILIZATION OF DRUG SUBSTANCES (OR ACTIVE PHARMACEUTICAL INGREDIENTS; APIS) AND DRUG PRODUCTS IS A CHALLENGING APPLICATION DUE TO THE COMPLEXITIES OF MANY DRUGS AND BIOLOGICS AND THE MINIMAL COMPATIBILITY OF CURRENT STERILIZATION MODALITIES (E.G., STEAM, RADIATION, ETHYLENE OXIDE). STERILIZATION IN THE PHARMACEUTICAL INDUSTRY IS TYPICALLY RESERVED ONLY FOR DRUG SUBSTANCES THAT MOVE ONTO FINAL ASSEMBLY (I.E., ASEPTIC PROCESSING AND PACKAGING), WHICH DOES NOT PROVIDE THE LEVEL OF PROTECTION OF STERILIZATION. PRODUCTS INTENDED TO BE STERILE SHOULD BE TERMINALLY STERILIZED IN THEIR FINAL CONTAINER WHENEVER POSSIBLE (REFERRED TO AS TERMINAL STERILIZATION) ACCORDING TO THE FDA. HOWEVER, THERE ARE VERY FEW DRUG PRODUCTS THAT UTILIZE TERMINAL STERILIZATION, AND WITH RESPECT TO DRUG PRODUCTS IN SEALED CONTAINERS (E.G., LYOPHILIZED DRUGS OR FORMULATED DRUGS) OR PREFILLED SYRINGES, THE ONLY OPTION FOR DRUG COMPANIES IS TO USE ASEPTIC PROCESSING FOR FINAL ASSEMBLY OF THESE PRODUCTS, WHICH IS A TIME CONSUMING AND RESOURCE HEAVY PROCESS. WHILE THE GLOBAL STERILIZATION SERVICES MARKET FOR DRUGS IS SIGNIFICANT AT ROUGHLY $6 BILLION USD, OFFERING SOLUTIONS TO DRUG MANUFACTURERS FOR TERMINALLY STERILIZING DRUG CONTAINING END PRODUCTS WOULD BE A GAME CHANGER. THE GLOBAL PREFILLED SYRINGE MARKET ALONE IS ESTIMATED TO BE $5.4 BILLION USD BY THE END OF 2021, AND CURRENTLY, THE ONLY SOLUTION FOR FINAL ASSEMBLY OF THESE PRODUCTS IS THROUGH ASEPTIC PROCESSING. THIS REPRESENTS A SIGNIFICANT OPPORTUNITY FOR THE NOVASTERILIS NOVAAPI™ SOLUTION, WITH THE POTENTIAL FOR ENORMOUS UPSIDE IN PROVIDING SAFER PRODUCTS, ELIMINATING THE NEED FOR ASEPTIC PROCESSING FOR PROCESS-COMPATIBLE PRODUCTS AND EXPANDING ON THE NUMBER AND TYPE OF DRUG SUBSTANCES/PRODUCTS THAT CAN BE TERMINALLY STERILIZED. PREVIOUS RESEARCH RESULTS SUPPORT CONTINUED DEVELOPMENT OF THE NOVASTERILIS PLATFORM FOR STERILIZATION OF DRUG SUBSTANCES AND PRODUCTS WITH THE POTENTIAL FOR DEVELOPING A TERMINAL STERILIZATION PROCESS FOR FINAL DRUG PRODUCTS IN VIAL/SYRINGE FORMAT. WE HAVE PARTNERED WITH A GLOBAL LEADER IN STERILIZATION SERVICES FOR THE BROADER PROGRAM, WHICH SHOULD PROVIDE SIGNIFICANT APPLICATION, CUSTOMER, AND MARKET INSIGHT TO THE PROJECT. IFYBER HAS PROPOSED THE FOLLOWING SPECIFIC AIMS IN THIS FAST TRACK PROPOSAL TO PREPARE NOVAAPI™ FOR COMMERCIALIZATION: PHASE I SPECIFIC AIMS: · AIM 1: ESTABLISH A DRUG SUBSTANCE COMPATIBILITY MATRIX FOR A SELECT NUMBER OF DRUGS USING NOVAAPI™ · AIM 2: ESTABLISH BASELINE CONDITIONS FOR TERMINAL STERILIZATION OF END PRODUCTS PHASE II SPECIFIC AIMS: · AIM 3: COMPLETE ASSESSMENT OF STERILIZATION VALIDATION PROCESS FOR SAL 10-6 FOR DRUG SUBSTANCES/PRODUCTS. · AIM 4: COMPLETE STERILIZATION RESIDUALS TESTING FOLLOWING REGULATORY GUIDELINES. · AIM 5: ESTABLISH SCALE UP PROCESS PARAMETERS AND LOAD CONFIGURATION IN A 100L VESSEL.
Obligated Amount:
1995655.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-04-29
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
107507.00
Total Face Value Of Loan:
107507.00
Date:
2017-01-18
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
OPTIMIZATION OF SUPERCRITICAL CARBON DIOXIDE BASED VIRUS INACTIVATION, CHARACTERIZED BY PROTEIN DAMAGE AND MAINTENANCE OF EPITOPE INTEGRITY IN VACCINE STERILIZATION
Obligated Amount:
1039821.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2015-06-15
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
OPTIMIZATION OF SUPERCRITICAL CARBON DIOXIDE BASED VIRUS INACTIVATION, CHARACTERIZED BY PROTEIN DAMAGE AND MAINTENANCE OF EPITOPE INTEGRITY IN VACCIN
Obligated Amount:
141052.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2015-01-16
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
SPOROCIDAL MECHANISM AND INLINE MONITORING OF PERACETIC ACID IN SUPERCRITICAL CO2
Obligated Amount:
147340.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Paycheck Protection Program

Date Approved:
2020-04-29
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
107507
Current Approval Amount:
107507
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
108243.35

Court Cases

Court Case Summary

Filing Date:
2016-01-25
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Defendant demands jury
Nature Of Suit:
Patent

Parties

Party Name:
NOVASTERILIS, INC.
Party Role:
Plaintiff
Party Name:
PRECISION ALLOGRAFT SOLUTIONS,
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Related by officers

ANTHONY EISENHUT

ARE1508 SD, LLC

Related by address

No related companies by address

Date of last update: 31 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated